Phase II study of mitozolomide (M & B 39,565) in colorectal and breast cancer.

Herait, P; Rougier, P; Oliveira, J; Delgado, F M; May-Levin, F; Hayat, M; Armand, J P

Herait, P; Rougier, P; Oliveira, J; Delgado, F M; May-Levin, F; Hayat, M; Armand, J P.

Affiliation

Herait P; Department of Medicine, Institut Gustave-Roussy, Villejuif, France.

Invest New Drugs ; 6(4): 323-5, 1988 Dec.

Article in En | MEDLINE | ID: mdl-3229944

Subject(s)

Adenocarcinoma/drug therapy; Antineoplastic Agents/therapeutic use; Breast Neoplasms/drug therapy; Colorectal Neoplasms/drug therapy; Nitrogen Mustard Compounds/therapeutic use; Adult; Antineoplastic Agents/adverse effects; Drug Evaluation; Female; Humans; Male; Middle Aged; Nitrogen Mustard Compounds/adverse effects

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Colorectal Neoplasms / Adenocarcinoma / Antineoplastic Agents / Nitrogen Mustard Compounds Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Invest New Drugs Year: 1988 Document type: Article Affiliation country: France

Search on Google

Add to My VHL

XML

PubMed Links